Awards as PI
Program Type | Institution | Grant Title | Award Value |
---|---|---|---|
Quest - Discovery Stage Research Projects | Stanford University | GENE EDITING FOR FOXP3 IN HUMAN HSC | $984,228 |
Late Stage Preclinical Projects | Stanford University | IND-enabling activities for a Phase 1 Study of Autologous CD4LVFOXP3 T Cells in Subjects with IPEX Syndrome | $5,002,496 |
Clinical Trial Stage Projects | Stanford University | Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome | $11,999,179 |
Total: $17,985,903.00 |
Publications
- Clin Transl Immunology 2020 Human-engineered Treg-like cells suppress FOXP3-deficient T cells but preserve adaptive immune responses in vivo. (PubMed: 33304583)